• Parkinson’s Research

  Benefits of Drug for Parkinson’s-Related Psychosis Outweigh Risks

  Posted by Forum Moderator on September 27, 2018 at 6:12 pm

  The FDA has concluded that the benefits of Acadia’s Nuplazid for people with Parkinson’s-related psychosis outweigh the risks and found no new safety concerns. Click here to learn more.

  Have you experienced psychosis or any other mental health challenges since being diagnosed with Parkinson’s? How are you coping with these challenges?

  replied 7 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply